SCHEMBL370588

SCHEMBL370588

Cc1cc2c(F)c(C)ccc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.50
NFE2L2 Q16236 1/20 0.50
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
GAA P10253 3/20 0.44
MAPT P10636 3/20 0.44
RXFP1 Q9HBX9 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NQO2 P16083 1/20 0.42
HPGD P15428 4/20 0.42
CYP1A2 P05177 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 2/20 0.40
ALOX15 P16050 2/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32889381 0.83 KEAP1 (0.50) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL12475636 0.83 KEAP1 (0.50) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL2535316 0.80 KEAP1 (0.51) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL3524315 0.80 KEAP1 (0.47) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL296024 0.80 KEAP1 (0.47) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL4424885 0.79 NQO2 (0.57) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL19668867 0.77 KEAP1 (0.45) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL296452 0.77 KDR (0.53) KEAP1NFE2L2ALDH1A1HPGDKDR
SCHEMBL12822231 0.76 MPO (0.44) KEAP1NFE2L2ALDH1A1KDM4EGAA
SCHEMBL12803649 0.76 KEAP1 (0.44) KEAP1NFE2L2ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024039858-A1 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF OLEMA PHARMACEUTICALS, INC. (US) 2024-02-22 WO disclosed
EP-3261638-B1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE INC (US) 2019-05-08 EP disclosed
WO-2017098421-A1 BENZOTHIADIAZINE COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-06-15 WO disclosed
EP-1474420-B1 QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2012-03-14 EP disclosed
WO-2009030224-A2 NOVEL QUINAZOLINE COMPOUNDS AND THE USE THEREOF FOR TREATING CANCEROUS DISEASES SCHEBO BIOTECH AG (DE) 2009-03-12 WO disclosed
EP-1309587-B1 CINNOLINE COMPOUNDS ASTRAZENECA AB (SE) 2008-12-31 EP disclosed